STOCK TITAN

eXoZymes shareholders elect six directors at 2026 meeting

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

eXoZymes Inc. (EXOZ) reported that shareholders at its November 13, 2026 annual meeting elected six director nominees to serve until the 2027 annual meeting and until successors are duly elected and qualified, and ratified RBSM LLP’s appointment as independent registered public accounting firm for the fiscal year ending December 31, 2026. 6,393,039 votes were represented at the meeting, equal to 68.70% of shares entitled to vote. There were 9,304,701 common shares outstanding on September 15, 2026, the record date.

Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Common shares outstanding 9,304,701 shares As of September 15, 2026, the record date for the annual meeting.
Votes represented 6,393,039 votes At the November 13, 2026 annual meeting.
Shares entitled to vote represented 68.70% At the annual meeting.
Director nominees elected 6 To serve until the 2027 annual meeting and until successors are duly elected and qualified.
Votes for auditor ratification 6,391,977 votes Ratification of RBSM LLP’s appointment for the fiscal year ending December 31, 2026.
Votes against auditor ratification 500 votes Ratification of RBSM LLP’s appointment.
Abstentions on auditor ratification 562 votes Ratification of RBSM LLP’s appointment.
Broker non-votes 340,251 votes Reported for Proposal 1, the director elections.
record date regulatory
"September 15, 2026, the record date for the Annual Meeting"
The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.
broker non-votes technical
"340,251 broker non-votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did EXOZ shareholders vote on at the 2026 annual meeting?

Shareholders elected six director nominees and ratified RBSM LLP’s appointment as independent registered public accounting firm for the fiscal year ending December 31, 2026.

How many votes supported EXOZ auditor ratification?

6,391,977 votes were cast for ratification, versus 500 against and 562 abstentions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0002010788 0002010788 2026-11-13 2026-11-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

Current Report Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

 

November 13, 2026

 

EXOZYMES INC.

(Exact name of registrant as specified in its charter)

 

Nevada   001-42204   83-4550057

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

750 Royal Oaks Drive, Suite 106

Monrovia, CA 91016

(Address of principal executive offices and zip code)

 

Registrant’s telephone number, including area code: (626) 415-1488

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   EXOZ   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.07 — Submission of Matters to a Vote of Security Holders

 

The 2026 Annual Meeting of Stockholders (the “Annual Meeting”) of eXoZymes Inc. (the “Company”) was held on November 13, 2026. At the Annual Meeting, the Company’s shareholders:

 

  ●

Elected six nominees to serve as directors until the 2027 annual meeting of shareholders and until their successors are duly elected and qualified; and

     
  ● Ratified the appointment of RBSM LLP, as our independent registered public accounting firm, for our fiscal year ending December 31, 2026.

 

There were outstanding, as of the close of business on September 15, 2026, the record date for the Annual Meeting, 9,304,701 shares of Common Stock of the Company, each entitled to one vote per shares. There were present at the Annual Meeting, either in person or represented by proxy, 6,393,039 votes, representing 68.70% of the shares entitled to vote at the Annual Meeting.

 

Proposals 1 had 340,251 broker non-votes.

 

The final number of votes cast for, against, withheld or abstaining with respect to each Proposal is set forth below.

 

Proposal 1  Shares For   Shares Against  

Shares

Abstaining

   Broker non-voting 
Christopher A. Marlett   6,050,804    654    1,330    340,251 
Anthony DiGiandomenico   6,045,885    6,627    276    340,251 
James U. Bowie   6,048,086    4,015    687    340,251 
James J. Lalonde   6,050,082    2,019    687    340,251 
Lon E. Bell   6,049,992    2,109    687    340,251 
Edgardo Rayo   6,047,658    4,553    577    340,251 

 

Proposal 2  Shares For   Shares Against  

Shares

Abstaining

 
Ratification of the appointment of RBSM LLP, as our independent registered public accounting firm, for our fiscal year ending December 31, 2026.   6,391,977    500    562 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 19, 2026 EXOZYMES INC.
     
  By /s/ Fouad Nawaz
    Fouad Nawaz
    VP of Finance (Principal Financial and Accounting Officer)

 

 

 

Filing Exhibits & Attachments

3 documents

Keep reading